NERVGEN PHARMA CORP. Total Assets
NERVGEN PHARMA CORP. (NGEN) had Total Assets of CAD 23.21 million as of 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:Assets · last filed 2026-03-31
- 2025-12-31: Assets 23.21M CAD.
- 2024-12-31: Assets 19.49M CAD.
| Period end | Assets |
|---|---|
| 2025-12-31 | 23.21M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 19.49M CAD 40-F · filed 2026-03-31 |